PTPROt inactivates the oncogenic fusion protein BCR/ABL and suppresses transformation of K562 cells.

Ähnliche Einträge

• PTPROt Inactivates the Oncogenic Fusion Protein BCR/ABL and Suppresses Transformation of K562 Cells
  von: Motiwala, Tasneem, et al.
  Veröffentlicht: (2009)
• Lyn Kinase and ZAP70 are substrates of PTPROt in B-cells: Lyn inactivation by PTPROt sensitizes leukemia cells to VEGF-R inhibitor Pazopanib
  von: Motiwala, Tasneem, et al.
  Veröffentlicht: (2010)
• Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.
  von: Nasser, Mohd W., et al.
  Veröffentlicht: (2018)
• 5-Aza-Deoxycytidine Induces Selective Degradation of DNA Methyltransferase 1 by a Proteasomal Pathway That Requires the KEN Box, Bromo-Adjacent Homology Domain, and Nuclear Localization Signal
  von: Ghoshal, Kalpana, et al.
  Veröffentlicht: (2005)
• Correction for Ghoshal et al., “5-Aza-Deoxycytidine Induces Selective Degradation of DNA Methyltransferase 1 by a Proteasomal Pathway That Requires the KEN Box, Bromo-Adjacent Homology Domain, and Nuclear Localization Signal”
  von: Ghoshal, Kalpana, et al.
  Veröffentlicht: (2018)